BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37161026)

  • 21. Association between MGMT status and response to alkylating agents in patients with neuroendocrine neoplasms: a systematic review and meta-analysis.
    Qi Z; Tan H
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32141507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should temozolomide be used on the basis of O
    Trillo Aliaga P; Spada F; Peveri G; Bagnardi V; Fumagalli C; Laffi A; Rubino M; Gervaso L; Guerini Rocco E; Pisa E; Curigliano G; Fazio N
    Cancer Treat Rev; 2021 Sep; 99():102261. PubMed ID: 34332293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Volumetric and MGMT parameters in glioblastoma patients: survival analysis.
    Iliadis G; Kotoula V; Chatzisotiriou A; Televantou D; Eleftheraki AG; Lambaki S; Misailidou D; Selviaridis P; Fountzilas G
    BMC Cancer; 2012 Jan; 12():3. PubMed ID: 22214427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of glioma stem cell marker CD133 and O6-methylguanine-DNA methyltransferase is associated with resistance to radiotherapy in gliomas.
    He J; Shan Z; Li L; Liu F; Liu Z; Song M; Zhu H
    Oncol Rep; 2011 Nov; 26(5):1305-13. PubMed ID: 21769436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation and expression profiles of MGMT gene in thymic epithelial tumors.
    Mokhtar M; Kondo K; Namura T; Ali AH; Fujita Y; Takai C; Takizawa H; Nakagawa Y; Toba H; Kajiura K; Yoshida M; Kawakami G; Sakiyama S; Tangoku A
    Lung Cancer; 2014 Feb; 83(2):279-87. PubMed ID: 24388682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).
    Cabrini G; Fabbri E; Lo Nigro C; Dechecchi MC; Gambari R
    Int J Oncol; 2015 Aug; 47(2):417-28. PubMed ID: 26035292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
    Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
    Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and clinicopathologic correlates of O⁶-methylguanine-DNA methyltransferase methylation status in patients with triple-negative breast cancer treated preoperatively by alkylating drugs.
    Fumagalli C; Della Pasqua S; Bagnardi V; Cardillo A; Sporchia A; Colleoni M; Viale G; Barberis M; Pruneri G
    Clin Breast Cancer; 2014 Aug; 14(4):285-90. PubMed ID: 24709436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of MMR, MGMT Promotor Methylation and Protein Expression on Overall and Progression-Free Survival in Primary Glioblastoma Patients Treated with Temozolomide.
    Brawanski KR; Sprung S; Freyschlag CF; Hoeftberger R; Ströbel T; Haybaeck J; Thomé C; Manzl C; Birkl-Toeglhofer AM
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patients.
    Fumagalli C; Pruneri G; Possanzini P; Manzotti M; Barile M; Feroce I; Colleoni M; Bonanni B; Maisonneuve P; Radice P; Viale G; Barberis M
    Breast Cancer Res Treat; 2012 Jul; 134(1):131-7. PubMed ID: 22228432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.
    Schambach A; Baum C
    DNA Repair (Amst); 2007 Aug; 6(8):1187-96. PubMed ID: 17482894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents.
    Kokkinakis DM; Ahmed MM; Delgado R; Fruitwala MM; Mohiuddin M; Albores-Saavedra J
    Cancer Res; 1997 Dec; 57(23):5360-8. PubMed ID: 9393761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysis.
    Sasai K; Nodagashira M; Nishihara H; Aoyanagi E; Wang L; Katoh M; Murata J; Ozaki Y; Ito T; Fujimoto S; Kaneko S; Nagashima K; Tanaka S
    Am J Surg Pathol; 2008 Aug; 32(8):1220-7. PubMed ID: 18580490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting O6-Methylguanine-DNA Methyltransferase Protein Expression in Primary Low- and High-Grade Gliomas Using Certain Qualitative Characteristics of Amide Proton Transfer-Weighted Magnetic Resonance Imaging.
    Su L; Gao P; Lin S; Wu B; Qin W; Lin Y; Xue J
    World Neurosurg; 2018 Aug; 116():e814-e823. PubMed ID: 29803064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. O(6)-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers.
    Wu PF; Kuo KT; Kuo LT; Lin YT; Lee WC; Lu YS; Yang CH; Wu RM; Tu YK; Tasi JC; Tseng HM; Tseng SH; Cheng AL; Lin CH
    Lung Cancer; 2010 Jun; 68(3):484-90. PubMed ID: 19740564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic impact of O6-methylguanine DNA methyltransferase and epidermal growth factor receptor expressions on primary gliosarcoma: a clinicopathologic and immunohistochemical study of seven cases at a single institution.
    Lin JW; Wu YT; Chang IW
    Indian J Pathol Microbiol; 2011; 54(4):683-7. PubMed ID: 22234090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel mechanism whereby nuclear factor kappaB mediates DNA damage repair through regulation of O(6)-methylguanine-DNA-methyltransferase.
    Lavon I; Fuchs D; Zrihan D; Efroni G; Zelikovitch B; Fellig Y; Siegal T
    Cancer Res; 2007 Sep; 67(18):8952-9. PubMed ID: 17875738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of the histone H3 lysine 4 methyltransferase MLL4 and the histone H3 lysine 27 demethylase UTX prolonging the overall survival of patients with glioblastoma and a methylated MGMT promoter.
    Kim J; Lee SH; Jang JH; Kim MS; Lee EH; Kim YZ
    J Neurosurg; 2017 May; 126(5):1461-1471. PubMed ID: 27367247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation is a rare event in soft tissue sarcoma.
    Jakob J; Hille M; Sauer C; Ströbel P; Wenz F; Hohenberger P
    Radiat Oncol; 2012 Oct; 7():180. PubMed ID: 23110891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of chromosomes 1p and 19q status and expressions of O6-methylguanine DNA methyltransferase (MGMT), p53 and Ki-67 in diffuse gliomas of World Health Organization (WHO) grades II and III: a clinicopathological study.
    Huang L; Jiang T; Yuan F; Li GL; Cui Y; Liu EZ; Wang ZC
    Neuropathol Appl Neurobiol; 2009 Aug; 35(4):367-379. PubMed ID: 19019173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.